Who invested in Akari Therapeutics?
Akari Therapeutics's investors include New Enterprise Associates, Venrock, RA Capital Management, Deerfield and Vivo Capital, and 2 more on record.
United Kingdom · Funded startup
2 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Akari Therapeutics and see its new rounds in your feed.Start following
Funding summaryUpdated 1 Nov 2026
$88Mraised across 2 rounds since 2013, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $75M sold, first sale Sept 2015
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Akari Therapeutics's investors include New Enterprise Associates, Venrock, RA Capital Management, Deerfield and Vivo Capital, and 2 more on record.
Akari Therapeutics has raised $88M across 2 rounds since 2013.
Akari Therapeutics's most recent round was an Undisclosed round of $75M in Sept 2015.
Its most recent round, $75M in Sept 2015, is also its largest on record.
Akari Therapeutics's first round on record, in Sept 2015, was backed by New Enterprise Associates, Venrock and RA Capital Management and 4 others.
Akari Therapeutics's latest named round is an Undisclosed round, in Sept 2015.
Akari Therapeutics is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.